新生儿继发性呼吸暂停83例临床分析  

Secondary apnea in neonate:Clinical analysis of 83 cases

作　　者：郭筱枝[1] 

机构地区：[1]蚌埠铁路中心医院儿科

出　　处：《蚌埠医学院学报》1997年第3期164-165,共2页Journal of Bengbu Medical College

摘　　要：目的：进一步阐明新生儿继发性呼吸暂停的常见病因及氨茶碱疗效。方法：对８３例新生儿继发性呼吸暂停的临床分析及氨茶碱和洛贝林治疗进行比较，用统计学卡方检验。结果：在新生儿继发性呼吸暂停的病因中，呼吸系统疾病占早产儿４３％（１９／４４），足月儿３１％（１０／３２），氨茶碱和洛贝林治疗结果的差异显著（Ｐ＜０．０５）。结论：新生儿继发性呼吸暂停无论早产儿还是足月儿，呼吸系统疾病为最常见原因。氨茶碱是防治其反复发作的有效药物。Objective:The purpose of the paper is to analyse the common causes of secondary apnea in newborn babies and the curative effect of aminophylline.Methods:Aminophylline and lobeline hydrochloride were used in treatment of 83 newborn babies with intermittent apnea and statistics by tested in Chi square test for comparison.Results:Respiratory diseases account for 43% of preterm babies(19/44) and 31% of full term babies(10/32).The difference in therapeutic effects between aminophylline and lobeline hydrochloride was remarkable ( P <0.05).Conclusions:Secondary apnea is commonly seen in newborn babies,premature or full term,and aminophylline is an effective medicine to prevent their repeated occurrences.

关 键 词：呼吸暂停 新生儿 氨茶碱 病因 

分 类 号：R722.12[医药卫生—儿科]